Beryl Drugs Ltd — Quarterly Results & Earnings

₹19.28

-9.36%

Profit Growth YoY0.00%Latest quarter

Sales Growth YoY-8.51%Latest quarter

Sales CAGR 5Y10.60%5 year compound

Profit CAGR 5Y63.26%5 year compound

📋

Quarterly Performance

YoY Profit Growth+0.00%

⚠️ Mild contraction

YoY Sales Growth-8.51%

⚠️ Mild contraction

OPM 5Y Average

Operating profit margin

7.18%

EPS Growth 5Y

63.26%

Interest Coverage

Higher = safer debt servicing

2.55

ROE

6.30%

ROCE

10.15%

💡

Growth Analysis

Beryl Drugs Ltd reported YoY profit growth of 0.00% and revenue growth of -8.51% in the latest quarter. Mild profit contraction — investigate if one-time or structural. Over 5 years, sales compounded at 10.60% and profits at 63.26% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Beryl Drugs Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.